P847: How clinical trial-inclusion criteria are failing phenylketonuria patients and risking exhaustion of the eligible patient population.
Main Authors: | Claire Oliver, Amy Oliver, Brian Oliver |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-01-01
|
Series: | Genetics in Medicine Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S294977442400904X |
Similar Items
-
Time to broaden the eligibility criteria in paediatric oncology trials? An analysis of patients with rhabdomyosarcoma non-eligible to the EpSSG RMS2005 trial
by: Gianni Bisogno, et al.
Published: (2023-01-01) -
Translating evidence into practice: eligibility criteria fail to eliminate clinically significant differences between real-world and study populations
by: Amelia J. Averitt, et al.
Published: (2020-05-01) -
How many patients with multiple sclerosis are ever eligible for therapeutic trials?
by: Wingerchuk, D, et al.
Published: (2000) -
847 Pharmacokinetics and pharmacodynamics of GS-3583 in cynomolgus monkeys
by: Brian Carr, et al.
Published: (2021-11-01) -
Opportunities for Participation in Randomized Controlled Trials for Patients with Multiple Myeloma: Trial Access Depends on Restrictive Eligibility Criteria and Patient Expectations
by: Amelie Boquoi, et al.
Published: (2022-04-01)